Synopsis: GLP-1 drugs can support weight loss and diabetes control, but they cannot replace diet, exercise, and healthy habits
In the mitochondrial matrix, PCT2 transformes valproylcarnitine into valproyl-CoA, which is able to enter a slow -oxidation process [26]
They also show antioxidant and anti-inflammatory properties, supporting protection against oxidative stress
For individuals who discontinue treatment and experience significant weight regain, restarting the medication may be considered, though evidence specifically studying this approach is limited
Triggers for GHRH secretion include: Deep sleep (especially stages 3 and 4) Hypoglycemia (low blood sugar) Certain amino acids (e.g., arginine, ornithine) 2
These areas are chosen because they have large muscle masses and relatively few blood vessels and nerves, making the injection process safer and more comfortable for the individual receiving the injection